semaglutide

AssetPeptideAlso Semaglutide Injection, TQF3510, GP40221, HD1916

GLP-1 receptor agonist

Stage
Approved
Modality
Peptide
Target
Insulin/IGF-1 signalling
Indications
32
Trials
353
Developers
9

Indications

32

29 more

  • Targets and what it contains4
  • Owner and partners9
  • Trials353
  • Evidence for its targets5
  • Competitors12
  • Aging relevance2
  • Signals15

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 54 sources

Assets